NEW YORK, NY / ACCESS Newswire / February 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning poss
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning poss

Michael Burry's latest stock bet is skyrocketing

05:59am, Wednesday, 19'th Feb 2025
Michael Burry of ‘The Big Short' fame earned the admiration of investors all over the world by correctly predicting and profiting off of the 2008 subprime mortgage crisis.
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning poss
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning poss
LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Oscar Health, Inc. ("Oscar Health" or "the Company") (NYSE: OSCR) fo
LOS ANGELES--(BUSINESS WIRE)--Oscar Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OSCR.
Oscar Health, Inc. (NYSE:OSCR ) Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ET Company Participants Chris Potochar – Vice President of Treasury and Investor Relations Mark Bertolini �
The U.S. healthcare sector has undergone a rapid digital transformation in recent years, driven by a combination of regulatory shifts, consumer demand and technological advancements. The pandemic acce
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.66 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $16.28, indicating a -0.12% shift from the previous trading day.
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $15.65, marking a -1.57% move from the previous day.
Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 years. Despite not being profitable yet, Oscar Health is projected to achieve
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE